All News Anebulo Pharmaceuticals, Inc.

Equities

ANEB

US0345691036

Market Closed - Nasdaq Other stock markets 03:59:28 2024-05-21 pm EDT			5-day change	1st Jan Change
2.11 ^USD	-1.86%		-7.46%	-12.81%

Feb. 13	Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates	May. 15	BU
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 13	CI
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates	Feb. 13	BU
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates	Nov. 14	BU
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors	23-10-09	AQ
Anebulo Pharmaceuticals Announces New CEO	23-10-09	AQ
Anebulo Pharmaceuticals Appoints New CEO	23-10-06	MT
Anebulo Pharmaceuticals Announces New CEO	23-10-06	BU
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors	23-10-06	BU
Anebulo Pharmaceuticals, Inc. Appoints Richie Cunningham as CEO	23-10-06	CI
Anebulo Pharmaceuticals, Inc. Appoints Bimal Shah to Its Board of Directors	23-10-06	CI
Anebulo Pharmaceuticals Appoints Daniel George as Part-Time Finance Chief	23-09-29	MT
Anebulo Pharmaceuticals, Inc. Announces Chief Financial Officer Changes	23-09-29	CI
Anebulo Pharmaceuticals, Inc. Appoints Daniel George as Principal Financial Officer and Principal Accounting Officer	23-09-29	CI
Maxim Starts Anebulo Pharmaceuticals at Buy With $6 Price Target	23-09-21	MT
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates	23-09-20	BU
Anebulo Pharmaceuticals : Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates - Form 8-K	23-09-20	PU
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	23-09-20	CI
Kronos Bio Appoints Sandra Gardiner as Interim Chief Financial Officer	23-09-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Anebulo Pharmaceuticals, Inc.

Equities

ANEB

US0345691036

All News

Filters